Brief: Plus Therapeutics Announces New Category III CPT Code
25/02/2026 12:39
Feb 25 (Reuters) - Plus Therapeutics Inc PSTV.O: PLUS THERAPEUTICS ANNOUNCES NEW CATEGORY III CPT CODE FOR CONVECTION-ENHANCED DELIVERY USED WITH REYOBIQ™ PLUS THERAPEUTICS INC: ARE ON TRACK TO COMPLETE ENROLLMENT IN PHASE 2 RECURRENT GLIOBLASTOMA TRIAL IN 2026 PLUS THERAPEUTICS INC - NEW CPT CODE EFFECTIVE JANUARY 1, 2027 Source text: ID:nGNXbdBvvm Further company coverage: PSTV.O (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Cerenome
See all newsBrief: Cerenome Secures In-Network Agreement With Florida Blue For Cnside® Csf Tumor Cell Enumeration And Molecular Profile Tests
Plus Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Cerenome Secures In-Network Agreement With Health Care Service Corporation
Plus Therapeutics Inc expected to post a loss of 91 cents a share - Earnings Preview
Brief: Plus Therapeutics Secures Regional Coverage Agreement With Medical Mutual For CNSide Cerebrospinal Fluid Assay For Metastatic CNS Cancer